TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive In Brief: Schmidt Sells OMB On Training Grants, But Weinberger Is The One To Convince December 21, 1973